Frequency-dependent inhibition of neuronal activity by topiramate in rat hippocampal slices

British Journal of Pharmacology

Volumn 125, Issue 4, 1998, Pages 826-832

  Wu, Shang Peng ^a   Tsai, Jing Jane ^a   Gean, Po Wu ^a  

^a NATIONAL CHENG KUNG UNIVERSITY   (Taiwan)

Author keywords

Anticonvulsant; Hippocampus; Sodium channel; Synaptic transmission; Topiramate

Indexed keywords

ANTICONVULSIVE AGENT; BICUCULLINE; TOPIRAMATE;

ANIMAL TISSUE; ANTICONVULSANT ACTIVITY; ARTICLE; BRAIN SLICE; DRUG MECHANISM; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; INHIBITORY POSTSYNAPTIC POTENTIAL; MALE; NERVE POTENTIAL; NONHUMAN; PRIORITY JOURNAL; RAT; SPIKE;

ACTION POTENTIALS; ANIMALS; ANTICONVULSANTS; EXCITATORY POSTSYNAPTIC POTENTIALS; FRUCTOSE; GAMMA-AMINOBUTYRIC ACID; HIPPOCAMPUS; MALE; NERVE BLOCK; PRESYNAPTIC TERMINALS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0031787518     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjp.0702096     Document Type: Article

References (33)

1. ANDREASEN, M., LAMBERT, J.D.C. & JENSEN, M.S. (1989). Effects of new non-N-methyl-D-aspartate antagonists on synaptic transmission in the in vitro rat hippocampus. J. Physiol., 414, 317-336.
2. + current. Comparison with the effects of phenytoin, carbamazepine, lidocaine and flumazenil. Brain Res., 548, 41-49.
3. BEN-MENACHEM, E., HENRIKSEN, O., DAM, M., MIKKELSEN, M., SCHMIDT, D., REID, S., REIFE, R., KRÄMER, L., PLEDGER, G. & KARIM, R. (1996). Double-blind, placebo-controlled trial of topiramate as add-on therapy in patients with refractory partial seizures. Epilepsia, 37, 539-543.
4. CHAPMAN, A.G., SMITH, S.E. & MELDRUM, B.S. (1991). The anticonvulsant effect of the non-NMDA antagonists, NBQX and GYKI 52466, in mice. Epilepsy Res., 9, 92-96.
5. CHENG, L.L., WANG, S.J., TSAI, J.J. & GEAN, P.W. (1997). Effects of phenytoin on the amygdala neurons in vitro. Pharmacology, 55, 228-234.
6. COLLINGRIDGE, G.L., KEHL, S.J. & MCLENNAN, H. (1983). Excitatory amino acids in synaptic transmission in the Schaffer collateral-commissural pathway of the rat hippocampus. J. Physiol., 334, 33-46.
7. COLLINGRIDGE, G.L. & LESTER, R.A.J. (1989). Excitatory amino acid receptors in the vertebrate central nervous system. Pharmacol. Rev., 40, 143-210.
8. COULTER, D.A., SOMBATI, S. & DELORENZO, R.J. (1993). Selective effects of topiramate on sustained repetitive firing and spontaneous bursting in cultured hippocampal neurons. Epilepsia, 34, S123.
9. CREAGER, R., DUNWIDDIE, T. & LYNCH, G. (1980). Paired-pulse and frequency facilitation in the CA1 region of the in vitro rat hippocampus. J. Physiol., 299, 409-424.
10. DUNWIDDIE, T. MUELLER, A. PALMER, M., STEWART, J. & HOFFER, B. (1980). Electrophysiological interactions of enkephalins with neuronal circuitry in the rat hippocampus. I. Effects on pyramidal cell activity. Brain Res., 184, 311-330.
11. EDMONDS JR. H.L., JIANG, Y.D., ZHANG, P.Y. & SHANK, R.P. (1996). Anticonvulsant activity of topiramate and phenytoin in a rat model of ischemia-induced epilepsy. Life Sciences, 59, 127-131.
12. FAUGHT, E., WILDER, B.J. RAMSAY, R.E. REIFE, R.A., KRAMER, L.D., PLEDGER, G.W. & KARIM, R.M. (1996). Topiramate placebo-controlled dose-ranging trial in refractory partial epilepsy using 200-, 400-, and 600-mg daily dosage (and the T.Y.S. group). Neurology, 46, 1684-1690.
13. GALARRETA, M., BUSTAMANTE, J., MARTIN DEL RIO, R. & SOLIS, J.M. (1996). Taurine induces a long-lasting increase of synaptic efficacy and axon excitability in the hippocampus. J. Neurosci., 16, 92-102.
14. GRANGER, P., BITON, B., FAURE, C., VIGE, X., DEPOORTERE, H., GRAHAM, D., LANGER, S.Z., SCATTON, B. & AVENET, P. (1995). Modulation of the γ-aminobutyric acid type A receptor by the antiepileptic drugs carbamazepine and phenytoin. J. Pharmacol. Exp. Ther.,47, 1189-1196.
15. LEACH, M.J., MARDEN, C.M. & MILLER, A.A. (1986). Pharmacological studies on lamotrigine, a novel potential antiepileptic drug: II. Neurochemical studies on the mechanism of action. Epilepsia, 27, 490-497.
16. LOSCHER, W. (1998). New visions in the pharmacology of anticonvulsion. Eur. J. Pharmac., 342, 1-13.
17. MANABE, T., WYLLIE, D.J.I. & NICOLL, R.A. (1993). Modulation of synaptic transmission and long-term potentiation: effects on paired-pulse facilitation and EPSP variance in the CA1 region of the hippocampus. J. Neurophysiol., 70, 1451-1459.
18. MELDRUM, B.S. (1995). Neurotransmission in epilepsy. Epilepsia, 36, S30-S35.
19. NAKAMURA, J., TAMURA, S., KANDA, T., ISHII, A., ISSHIHARA, K., SERIKAWA, T., YAMADA, J. & SASA, M. (1994). Inhibition by topiramate of seizures in spontaneously epileptic rats and DBA 2 mice. Eur. J. Pharmacol., 254, 83-89.
20. OLSEN, R.W. & AVOLI, M. (1997). GABA and epileptogenesis. Epilepsia, 38, 399-407.
21. ROGAWSKI, M.A. & PORTER, R.J. (1990). Antiepileptic drugs: pharmacological mechanisms and clinical efficacy with consideration of promising developmental stage compounds. Pharmacol. Rev., 42, 223-286.
22. SCHULZ, P.E., COOK, E.P. & JOHNSTON, D. (1994). Changes in paired-pulse facilitation suggest presynaptic involvement in long-term potentiation. J. Neurosci., 14, 5325-5337.
23. SEVERT, L., COULTER, D.A., SOMBATI, S. & DELORENZO, R.J. (1995). Topiramate selectively blocks kainate currents in cultured hippocampal neurons. Epilepsia, 36, S38.
24. SHANK, R.P. (1995). Preclinical profile of topiramate, a novel anticonvulsant. Adv. AED. Ther., 1, 1-6.
25. SHANK, R.P., GARDOCKI, J.F., VAUGHT, J.L., DAVIS, C.B., SCHUPSKY, J.J., RAFFA, R.B., DODGSON, S.J., NORTEY, S.O. & MARYANOFF, B.E. (1994). Topiramate: Preclinical evaluation of a structurally novel anticonvulsant. Epilepsia, 35, 449-460.
26. 2+ currents in cortical neurons: functional implications. Eur. J. Pharmac., 307, 113-116.
27. TASSINARI, C.A., MICHELUCCI, R., CHAUVEL, P., CHODKIEWICZ, J., SHORVON, S., HENRIKSEN, O. DAM, M. REIFE, R., PLEDGER, G. & KARIM, R. (1996). Double-blind, placebo-controlled trial of topiramate (600 mg daily) for the treatment of refractory partial epilepsy. Eplepsia, 37, 763-768.
28. WANG, S.J., HUANG, C.C., HSU, K.S., TSAI, J.J. & GEAN, P.W. (1996). Presynaptic inhibition of excitatory neurotransmission by lamotrigine in the rat amygdalar neurons. Synapse, 24, 248-255.
29. WAUQUIER, A. & ZHOU, S. (1996). Topiramate: a potent anti-convulsant in the amygdala-kindled rat. Epilepsy Res., 24, 73-77.
30. WHITE, H.S., BROWN, S.D., WOODHEAD, J.H., SKEEN, G.A. & WOLF, H.H. (1997). Topiramate enhances GABA-mediated chloride flux and GABA-evoked chloride currents in murine brain neurons and increases seizure threshold. Epilepsy Res., 28, 167-179.
31. WILLOW, M., GONOI, T. & CATTERALL, W.A. (1985). Voltage clamp analysis of the inhibitory actions of diphenylhydantoin and carbamazepine on voltage-sensitive sodium channels in neuroblastoma cells. Mol. Pharmacol., 27, 549-558.
32. YAMAGUCHI, S., DONEVAN, S.D. & ROGAWSKI, M.A. (1993). Anticonvulsant activity of AMPA kainate antagonists: Comparison of GYK1 42466 and NBQX in maximal electroshock and chemoconvulsant seizure models. Epilepsy Res., 15, 179-184.
33. ZUCKER, R.S. (1989). Short-term synaptic plasticity. Ann. Rev. Neurosce., 12, 13-31.